Bosh sahifaGRAL • NASDAQ
add
Grail Inc
38,04 $
Seans yopilganidan keyin:(0,11%)-0,040
38,00 $
Yopilgan:12-sen, 20:00:00 (GMT-4) · USD · NASDAQ · Ogohlantirish
Yopilish kursi
38,65 $
Kunlik diapazon
36,87 $ - 38,47 $
Yillik diapazon
12,33 $ - 63,99 $
Bozor kapitalizatsiyasi
1,37 mlrd USD
Oʻrtacha hajm
794,20 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 35,54 mln | 11,18% |
Joriy xarajat | 146,55 mln | -37,88% |
Sof foyda | -113,98 mln | 92,81% |
Sof foyda marjasi | -320,69 | 93,53% |
Har bir ulushga tushum | -3,18 | — |
EBITDA | -91,68 mln | 49,34% |
Amaldagi soliq stavkasi | 25,43% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 602,75 mln | -37,14% |
Jami aktivlari | 2,70 mlrd | -17,34% |
Jami passivlari | 387,91 mln | -32,48% |
Umumiy kapital | 2,31 mlrd | — |
Tarqatilgan aksiyalar | 36,05 mln | — |
Narxi/balansdagi bahosi | 0,60 | — |
Aktivlardan daromad | -11,79% | — |
Kapitaldan daromad | -13,48% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -113,98 mln | 92,81% |
Operatsiyalardan naqd pul | -76,96 mln | 55,20% |
Sarmoyadan naqd pul | 70,37 mln | 5 177,13% |
Moliyadan naqd pul | — | — |
Naqd pulning sof oʻzgarishi | -6,47 mln | -100,85% |
Boʻsh pul | -29,88 mln | 75,95% |
Haqida
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California. It was previously a subsidiary of Illumina started as a startup seeking to develop an early cancer screening test for people who do not have symptoms.
Grail was spun-out from Illumina on June 24, 2024.
Their liquid biopsy was launched in June 2021 and is called the Galleri test. Wikipedia
Tashkil etilgan
2015
Sayt
Xodimlar soni
1 000
